http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A
.trig | .trig.txt | .jelly | .jelly.txt | .jsonld | .jsonld.txt | .nq | .nq.txt | .xml | .xml.txt
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix ns1: <https://w3id.org/np/o/ntemplate/> .
@prefix this: <http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A> .
@prefix sub: <http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo .
}
sub:assertion {
<http://purl.obolibrary.org/obo/DOID_409> biolink:category biolink:Disease .
sub:association a rdf:Statement;
rdf:object <http://purl.obolibrary.org/obo/DOID_409>;
rdf:predicate biolink:treats;
rdf:subject <https://identifiers.org/drugbank:DB01039>;
rdfs:label "\"Fenoglide is contraindicated in patients with severe renal dysfunction, including those receiving dialysis [see Clinical Pharmacology (12.3) Fenoglide is contraindicated in patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities [see Warnings and Precautions (5.1) Fenoglide is contraindicated in patients with gallbladder disease [see Warnings and Precautions (5.2) Fenoglide is contraindicated in nursing mothers [see Use in Specific Populations (8.3) Fenoglide is contraindicated in patients who have a known hypersensitivity to fenofibrate, such as severe skin rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis. [see Warnings and Precautions (5.9) Severe renal dysfunction, including patients receiving dialysis ( 4 12.3 Active liver disease ( 4 5.1 Gallbladder disease ( 4 5.2 Nursing mothers ( 4 8.3\"";
biolink:provided_by <https://w3id.org/um/NeuroDKG>;
biolink:relation schema:MedicalContraindication .
<https://identifiers.org/drugbank:DB01039> biolink:category biolink:Drug .
}
sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
npx:hasSignature "gzpouB/HsT/F/lyzDqXWhW5CLhxMdJPmxEF1OCJv9xXJyMPrF2E1c6a/olTYSsWtFlor8r57KVvu3vltR8+hvF8nALFeR1XdmRVCL2T7F4n4B/aOIWDVLD3LzXs0ZT5eW2yh3OhL+mm6AzO4maw3+8sAC20vVaKjdLVKB4ZEf8U=";
npx:hasSignatureTarget this: .
this: dct:created "2021-08-22T17:24:55.921+02:00"^^xsd:dateTime;
dct:creator orcid:0000-0002-1468-3557;
ns1:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
ns1:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
ns1:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
}